Pages that link to "Q33457702"

The following pages link to Activity of the alternative complement pathway after splenectomy: Comparison to activity in sickle cell disease and hypogammaglobulinemia (Q33457702):

Displaying 24 items.

• Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies (Q33821324) (← links)
• Systemic lupus erythematosus and sickle cell disease (Q33895818) (← links)
• Recurrent infections with IgG2 deficiency (Q35601887) (← links)
• Partial splenectomy in sickle cell syndromes (Q35626657) (← links)
• Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease (Q36426487) (← links)
• Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci (Q36966832) (← links)
• Systemic lupus erythematosus in patients with sickle cell disease (Q37000432) (← links)
• Defective activation of neutrophils after splenectomy (Q37196912) (← links)
• Complement in the pathophysiology and diagnosis of human diseases (Q39487716) (← links)
• Splenic function: physiology and splenic hypofunction (Q39665560) (← links)
• Sickle cell disease and infection (Q40137997) (← links)
• Postsplenectomy infection. (Q40301722) (← links)
• Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum (Q40830914) (← links)
• Serum IgG levels and complement activity in hypogammaglobulinaemic patients under substitution therapy (Q41561404) (← links)
• Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy. (Q41771388) (← links)
• Effect of anti-IL-6 and anti-10 monoclonal antibodies on the suppression of the normal T lymphocyte mitogenic response by steady state sickle cell disease sera (Q43904720) (← links)
• Type 2 cytokine serum levels in healthy sickle cell disease patients (Q46356173) (← links)
• Lymphocyte Blastogenic Responses in Sickle Cell Disease (Q46454934) (← links)
• Combined effects of in vitro penicillin and sickle cell disease sera on normal lymphocyte functions (Q46834225) (← links)
• Current treatment of sickle cell disease (Q71357958) (← links)
• Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization (Q71728538) (← links)
• Serum hemolytic factor D values in children with steroid-responsive idiopathic nephrotic syndrome (Q71939449) (← links)
• In vivo production of type 1 cytokines in healthy sickle cell disease patients (Q73370029) (← links)
• In VitroSuppression of the Normal Mitogenic T Lymphocyte Response by Steady State Sickle Cell Disease Sera (Q73942076) (← links)